Lumos Diagnostics Holdings Limited logo

Lumos Diagnostics Holdings Limited

ASX:LDX.AX

Overview | Financials
Company Name Lumos Diagnostics Holdings Limited
Symbol LDX.AX
Currency AUD
Price 0.034
Market Cap 28,097,066
Dividend Yield 0%
52-week-range 0.028 - 0.108
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. Douglas Ward
Website https://lumosdiagnostics.com

An error occurred while fetching data.

About Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral

Related Stocks

Althea Group Holdings Limited logo

Althea Group Holdings Limited

AGH.AX

0.04 AUD

Alterity Therapeutics Limited logo

Alterity Therapeutics Limited

ATH.AX

0.004 AUD

IDT Australia Limited logo

IDT Australia Limited

IDT.AX

0.127 AUD

Neurotech International Limited logo

Neurotech International Limited

NTI.AX

0.052 AUD

Resonance Health Limited logo

Resonance Health Limited

RHT.AX

0.052 AUD

Cryosite Limited logo

Cryosite Limited

CTE.AX

0.92 AUD

Compumedics Limited logo

Compumedics Limited

CMP.AX

0.29 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD